Publications

• Publication date : 30 June 2021 More

  Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real-life

  Liver Int.

  Authors : Asselah Tarik Loureiro Dimitri Fréderic Le Gal Narguet Stéphanie Ségolène Brichler Bouton Valérie Abazid Malek Boyer Nathalie Nathalie Giuly Athenais Gerber Tout Issam Alex Sarah Maylin Bed Cheikh Mohamed Marcellin Patrick Castelnau Corinne Emmanuel Gordien Mansouri Abdellah

• Publication date : 31 May 2021 More

  New therapies for hepatitis delta virus infection

  Liver Int.

  Authors : Loureiro Dimitri Castelnau Corinne Tout Issam Alex Boyer Nathalie Narguet Stéphanie Menasria Benazzouz Sabrina Louis Zeina Pons-Kerjean Nathalie Nathalie Giuly Marcellin Patrick Mansouri Abdellah Asselah Tarik

• Publication date : 31 January 2018 More

  Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?

  Liver Int .

  Authors : Asselah Tarik Marcellin Patrick Raymond F Schinazi

• Publication date : 14 November 2016 More

  Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression

  Gut. 2016 Nov;65(11):1882-1894

  Authors : Loyer X Paradis Valérie Hénique C Vion AC Colnot N Guerin CL Devue C On S Scetbun J Romain M Paul JL Rothenberg ME Marcellin Patrick Durand François Bedossa Pierre Prip-Buus C Baugé E Staels B Boulanger CM Tedgui A Rautou Pierre-Emmanuel

• Publication date : 11 October 2016 More

  MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C

  Scientific Reports

  Authors : Kevin Appourchaux Dokmak Safi Matthieu Resche-Rigon Treton Xavier Martine Lapalus Charles-Henry Gattolliat Emmanuelle Porchet Michelle Martinot-Peignoux Boyer Nathalie Michel Vidaud Bedossa Pierre Marcellin Patrick Ivan Bièche Emilie Estrabaud Asselah Tarik

• Publication date : 31 May 2014 More

  Reduction of MicroRNA 122 Expression in IFNL3 CT/TT Carriers and during Progression of Fibrosis in Patients with Chronic Hepatitis C

  J Virol

  Authors : Estrabaud E Lapalus M Broët P Appourchaux K Muynck SD Lada O Martinot-Peignoux M Bièche I Valla Dominique Bedossa Pierre Marcellin Patrick Vidaud M Asselah Tarik

• Publication date : 09 October 2013 More

  IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients

  J Viral Hepat, 2013 Oct 10. doi: 10.1111/jvh.12177

  Authors : Zhang Q Lapalus M Asselah Tarik Laouénan C Moucari R Martinot-Peignoux M Bieche I Estrabaud E De Muynck S Boyer Nathalie Bedossa Pierre Vidaud M Marcellin Patrick Lada O

• Publication date : 08 February 2013 More

  Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

  Lancet, 2013. Feb 9;381(9865):468-75.

  Authors : Marcellin Patrick Gane E Buti M Afdhal N Sievert W Jacobson IM Washington MK Germanidis G Flaherty JF Schall RA Bornstein JD Kitrinos KM Subramanian GM McHutchison JG Heathcode EJ

• Publication date : 27 January 2013 More

  Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients

  J Hepatol, 2013 Jun;58(6):1089-95. doi: 10.1016/j.jhep.2013.01.028

  Authors : Martinot-Peignoux M Carvalho-Filho R Lapalus M Netto-Cardoso AC Lada O Batrla R Krause F Asselah Tarik Marcellin Patrick

• Publication date : 10 September 2011 More

  IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C

  J Hepatol, 2011. 56(3): p. 527-32

  Authors : Asselah Tarik De Muynck S Broet P Masliah-Planchon J Blanluet M Bieche I Lapalus M Martinot-Peignoux M Lada O Estrabaud E Zhang Q El Ray A Vidaud D Ripault MP Boyer Nathalie Bedossa Pierre Valla Dominique Vidaud M Marcellin Patrick